Universe Pharmaceuticals Inc
2 hedge funds and large institutions have $9.04K invested in Universe Pharmaceuticals Inc in 2025 Q3 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, reducing their positions, and 0 closing their positions.
0.36% more ownership
Funds ownership: 0% → 0.36% (+0.36%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Osaic Holdings
Scottsdale,
Arizona
|
+$7.59K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$4 |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Osaic Holdings
Scottsdale,
Arizona
| $9.04K | +$7.59K | +2,000 | New |
|
|
2
UBS Group
Zurich,
Switzerland
| $4 | +$4 | +1 | New |
|
UPC Hedge Fund Activity: Q3 2025 in Review
2 of the 7,622 institutional investors tracked by Wall St. Rank reported a position in Universe Pharmaceuticals Inc (UPC) for Q3 2025, worth a combined $9.04K.
Buyers outnumbered sellers: 2 funds opened new UPC positions and 0 closed out — a net gain of 2 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Osaic Holdings, opening a new position worth an estimated $7.59K.
- 2 institutional investors held Universe Pharmaceuticals Inc (UPC) as of Q3 2025, up from 0 in Q2 2025.
- Funds reported $9.04K of Universe Pharmaceuticals Inc stock for Q3 2025.
- 2 funds opened new Universe Pharmaceuticals Inc positions in Q3 2025 and 0 closed out, a net change of +2 holders.
- The largest Universe Pharmaceuticals Inc buyer in Q3 2025 was Osaic Holdings, an estimated $7.59K added.
Based on aggregated 13F filings for Q3 2025.